Methylation of the CD44 metastasis suppressor gene in human prostate cancer

Cancer Research

Volumn 59, Issue 10, 1999, Pages 2329-2331

  Lou, Wei ^a   Krill, Diane ^a   Dhir, Rajiv ^a   Becich, Michael J ^a   Dong, Jin Tang ^b   Frierson Jr , Henry F ^b   Isaacs, William B ^c   Isaacs, John T ^c   Gao, Allen C ^a  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^b UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOSINE; DNA;

ANEUPLOIDY; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; DNA METHYLATION; GENE AMPLIFICATION; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CANCER; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; TRANSCRIPTION REGULATION; TUMOR CLASSIFICATION; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA; ANTIGENS, CD44; CPG ISLANDS; DISEASE PROGRESSION; DNA METHYLATION; DNA, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; NEOPLASM METASTASIS; NEOPLASM PROTEINS; PROSTATECTOMY; PROSTATIC NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0033562994     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Gunthert, U., Stauder, R., Mayer, B., Terpe, H., Finke, L., and Friedrichs, K. Are CD44 variant isoforms involved in human tumor progression? Cancer Surv., 24: 19-42, 1995.
2. Screaton, G. R., Bell, M. V., Jackson, D. G., Cornelis, F. B., Gerth, U., and Bell, J. I. Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc. Natl. Acad. Sci. USA, 89: 12160-12164, 1992.
3. Rudzki, Z., and Jothy, S. CD44 and the adhesion of neoplastic cells. J. Clin. Pathol., 50: 57-71, 1997.
4. Underhill, C. CD44: the hyaluronan receptor. J. Cell Sci., 103: 293-298, 1992.
5. Aruffo, A., Stamenkovic, I., Melnick, M., Underhill, C. B., and Seed, B. CD44 is the principal cell surface receptor for hyaluronate. Cell, 61: 1303-1313, 1990.
6. Weber, G. F., Ashkar, S., Glimcher, M. J., and Cantor, H. Receptor-ligand interaction between CD44 and osteopontin (Eta-1). Science (Washington DC), 271: 509-512, 1996.
7. Gao, A. C., Lou, W., Dong, J. T., and Isaacs, J. T. CD44 is a metastasis suppressor gene for prostatic cancer located on human chromosome 11p13. Cancer Res., 57: 846-849, 1997.
8. Gao, A. C., Lou, W., Sleeman, J. P., and Isaacs, J. T. Metastasis suppression by the standard CD44 isoform does not require binding of prostate cancer cells to hyaluronate. Cancer Res., 58: 2350-2352, 1998.
9. Kallakury, B. V. S., Yang, F., Figge, J., Smith, K., Kausik, S. J., Tacy, N. J., Fisher, H. A. G., Kaufman, R., Figge, H., and Ross, J. S. Decreased levels of CD44 protein and mRNA in prostate carcinoma: correlation with tumor grade and ploidy. Cancer (Phila.), 78: 1461-1469, 1996.
10. DeMarzo, A. M., Bradshaw, C., Sauvageot, J., Epstein, J. I., and Miller, G. J. CD44 and CD44v6 downregulation in clinical prostate carcinoma: relation to Gleason grade and cytoarchitecture. Prostate, 34: 162-168, 1998.
11. Noordzij, M. A., Steenbrugge, G-J. V., Verkaik, N. S., Schroder, F. H., and Van der Kwast, T. H. The prognostic value of CD44 isoforms in prostate cancer patients treated by radical prostatectomy. Clin. Cancer Res., 3: 805-815, 1997.
12. Baylin, S. B., Makos, M., Wu, J. J., Yen, R. W., De Bustros, A., Vertino, P., and Nelkin, B. D. Abnormal pattern of DNA methylation in human neoplasia: potential consequences for tumor progression. Cancer Cells, 3: 383-390, 1991.
13. Jones, P. A. DNA methylation errors and cancer. Cancer Res., 56: 2463-2467, 1996.
14. Shtivelman, E., and Bishop, M. J. Expression of CD44 is repressed in neuroblastoma cells. Mol. Cell. Biol., 11: 5446-5453, 1991.
15. Gardiner-Garden, M., and Frommer, M. CpG islands in vertebrate genomes. J. Mol. Biol., 196: 261-282, 1987.
16. Goldstein, L. A., Zhou, D. F., Picker, L. J., Minty, C. N., Bargatze, R. F., Ding, J. F., and Butcher, E. C. A human lymphocyte homing receptor, the hermes antigen, is related to cartilage proteoglycan core and link proteins. Cell, 56: 1063-1072, 1989.